Back to companies

HEM Pharma Inc.

376270KRKRX

HEM파마

Revenue
₩15.1bn
FY2024
Operating income
-₩7.7bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)